Impact of late treatment-related radiotherapy toxicity, depression, and anxiety on quality of life in long-term breast cancer survivors

INTRODUCTION: This study aimed to assess the impact of late treatment toxicity (especially radiotherapy toxicity), chemoradiotherapy treatment type (concurrent or sequential), depression and anxiety on overall, physical and emotional quality of life (QoL) in long-term breast cancer survivors. Method. We assessed 117 patients (mean follow-up since the end of treatment = 8.1 years) for late radiotherapy toxicity (LENT-SOMA scale), patient and doctor ratings of breast cosmetic outcomes, QoL (EORTC QLQ-C30), depression and anxiety (Hospital and Anxiety Depression scale).

RESULTS: In univariate analyses, factors associated with significantly decreased QoL were: use of sequential treatment and decreased overall QoL (P = 0.002) and emotional QoL (P = 0.02) ; few radiotherapy late toxicity symptoms (pain and decreased physical QoL, P = 0.01 ; fibrosis and decreased emotional QoL, P = 0.04) ; probable depression or probable anxiety and decreased overall, physical and emotional QoL (P ≤ 0.005). In multivariate analyses, probable depression and probable anxiety were the most stronger predictors for decreased QoL in the overall, physical and emotional domains (P ≤ 0.02).

CONCLUSION: Improving screening for and treatment of depression and anxiety might improve QoL in long-term breast cancer survivors.

Medienart:

E-Artikel

Erscheinungsjahr:

2012

Erschienen:

2012

Enthalten in:

Zur Gesamtaufnahme - volume:99

Enthalten in:

Bulletin du cancer - 99(2012), 5 vom: 15. Mai, Seite 589-98

Sprache:

Französisch

Weiterer Titel:

Impact des complications tardives de la radiothérapie, de la dépression et de l'anxiété sur la qualité de vie à long terme dans le cancer du sein

Beteiligte Personen:

Brunault, Paul [VerfasserIn]
Toledano, Alain [VerfasserIn]
Aguerre, Colette [VerfasserIn]
Suzanne, Isabelle [VerfasserIn]
Garaud, Pascal [VerfasserIn]
Trzepidur-Edom, Magdalena [VerfasserIn]
Calais, Gilles [VerfasserIn]
Camus, Vincent [VerfasserIn]

Links:

Volltext

Themen:

Clinical Trial, Phase III
English Abstract
Journal Article
Multicenter Study

Anmerkungen:

Date Completed 11.07.2012

Date Revised 21.03.2022

published: Print

Citation Status MEDLINE

doi:

10.1684/bdc.2012.1569

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM21727630X